Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities

Ann Am Thorac Soc. 2019 May;16(5):534-539. doi: 10.1513/AnnalsATS.201812-863OT.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Anti-Bacterial Agents / administration & dosage*
  • Cystic Fibrosis / drug therapy*
  • Drug Development / methods*
  • Humans
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / isolation & purification

Substances

  • Anti-Bacterial Agents